Weekly Market Recap – Week Ending February 06, 2026 Market action last week depended heavily on where investors chose to look. Beneath largely unchanged headline index levels, sharp rotations continued across style, size, and geography. Value stocks outperformed growth by a wide margin, while large-cap technology names increasingly served as sources of funds for smaller-cap, … Read more
For today’s bulletin, we take a look at our latest STRONG BUY and BUY upgrades and focus on one of our top upgrades for the day, AstraZeneca $AZN. We also provide a link to download a FREE STOCK REPORT on the company. Overvaluation has declined below 60% and therefore we have ended our latest Valuation … Read more
This week, we provide top-five ranked VE data for our Basic Materials Sector stocks. We take a look at our latest data on Chemours Company $CC and provide a free download link for our stock report on the company. VALUATION WATCH: Overvalued stocks now make up 61.86% of our stocks assigned a valuation and 26.49% … Read more
This week, we provide top-five ranked VE data for our Medical Sector stocks. We take a look at our latest data on JPMorgan Chase $JPM and provide a free download link for our stock report on the company. Because overvaluation has crept up again, we now have another Valuation Watch. VALUATION WATCH: Overvalued stocks now … Read more
This week, we provide top-five ranked VE data for our Medical stocks. We take a look at our latest data on Twitter TWTR$ and provide a free download link for our stock report on the company. VALUATION WATCH: Overvalued stocks now make up 61.01% of our stocks assigned a valuation and 26.54% of those equities … Read more
This week, we provide top-five ranked VE data for our Health Care stocks. We take a look at our latest data on IBM $IBM. We currently have an overvaluation watch underway. VALUATION WATCH: Overvalued stocks now make up 61.45% of our stocks assigned a valuation and 25.36% of those equities are calculated to be overvalued … Read more
This week, we provide top-five ranked VE data for our Medical stocks. We take a look at our latest data on Intel $INTC. We currently have an overvaluation watch underway. VALUATION WATCH: Overvalued stocks now make up 64.57% of our stocks assigned a valuation and 31.59% of those equities are calculated to be overvalued by … Read more